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Abstract
Osteosarcoma is one of the most malignant tumors of childhood and adolescence that is often resistant to standard chemo-
and radio-therapy. Geldanamycin and geldanamycin analogs have been recently studied as potential anticancer agents for
osteosarcoma treatment. Here, for the first time, we have presented novel anticancer mechanisms of geldanamycin
biological activity. Moreover, we demonstrated an association between the effects of geldanamycin on the major heat
shock proteins (HSPs) and the overall survival of highly metastatic human osteosarcoma 143B cells. We demonstrated that
the treatment of 143B cells with geldanamycin caused a subsequent upregulation of cytoplasmic Hsp90 and Hsp70 whose
activity is at least partly responsible for cancer development and drug resistance. On the other hand, geldanamycin induced
upregulation of Hsp60 gene expression, and a simultaneous loss of hyperacetylated Hsp60 mitochondrial protein pool
resulting in decreased viability and augmented cancer cell death. Hyperacetylation of Hsp60 seems to be associated with
anticancer activity of geldanamycin. In light of the fact that mitochondrial dysfunction plays a critical role in the apoptotic
signaling pathway, the presented data may support a hypothesis that Hsp60 can be another functional part of
mitochondria-related acetylome being a potential target for developing novel anticancer strategies.
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Introduction
Osteosarcoma (OS) is one of the most aggressive malignant bone
neoplasms of childhood and adolescence. Remarkable progress
has been made in terms of improving surgical techniques
combined with neoadjuvant and adjuvant chemotherapy, howev-
er, the 5-year survival rate plateaued at 50–70% [1], [2]. The
main clinical problem with OS is high resistance to chemotherapy
[3], [4]. Molecular chaperones of heat shock protein family (HSPs)
play important roles in protein folding, translocation, as well as in
cell proliferation, apoptotic signaling, and metastasis [5]–[][7].
HSPs overexpression in the cell correlates with an increased risk of
cancer development or resistance to chemotherapy [5]. Thus,
HSPs are proposed to be considered as case-dependent specific
tumor biomarkers [5], [8]–[][][11]. Moreover, they play a pivotal
role in the cellular signaling, trafficking, and protein turnover.
There are three major families of HSPs whose expression and
activity are enhanced in cancer cells, namely the Hsp60, Hsp70,
and Hsp90 families [12]. It seems that different cellular
compartments such as mitochondria, cytoplasm or endoplasmic
reticulum (ER) have a unique set of molecular chaperones. The
most abundant eukaryotic HSP is Hsp90 as identified in two
cytoplasmic isoforms: Hsp90AA1 (Hsp90 alpha, Hsp90a, HSPC1),
Hsp90AB1 (Hsp90 beta, Hsp90b, HSPC3), and the ER homolog:
Glucose-regulated Protein 94 (GRP94, Hsp90B1), all of them
being expressed by distinct genes [13], [14]. In humans, there are
several Hsp70 family members including stress-inducible Hsp70
(Hsp72, HspA1), and constitutively expressed HSC70 (Hsp73,
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HspA8) [15]. For many years Hsp60 was considered an exclusively
mitochondrial chaperone. Surprisingly enough, Hsp60 was
discovered in the cytoplasm, and extracellular compartment
[16], [17].
Geldanamycin (GA) and geldanamycin analogs have been
considered potential anticancer agents in OS treatment [18]. GA
is a benzoquinone ansamycin antibiotic and a potent tyrosine
kinase inhibitor that was first isolated from Streptomyces hygrocopicus
in 1970. GA is also known as a potent inhibitor of Hsp90 [18]. GA
binds specifically to the N-terminal ATP binding site of Hsp90
destabilizing the Hsp90 heterocomplexes with target proteins, and
consequently leading to Hsp90-client proteins proteasomal degra-
dation [18]. The mechanisms involved in GA-induced destabili-
zation of Hsp90 complexes, and proteasomal degradation of
Hsp90-client proteins are relatively well understood. However,
very little is known about GA impact on modulation of HSPs
expression, and potential correlation with chemotherapy effec-
tiveness. It seems that GA influences HSPs expression by the
stabilization of the transcription factor HSF1 trimeric complex
with heat shock response element (HSE), and thus stimulates the
expression of HSPs coding genes [19]–[][21]. The therapeutic
usage of GA has been limited mainly due to hepatotoxicity,
however, less toxic GA analogs (17AAG, 17DMAG) have been
developed, and extensively tested [22]–[][24]. In this study, we
aimed to investigate various effects of GA on OS 143B cell line
focusing specifically on the viability, mode of GA-induced cell
death, impact on HSPs gene expression, protein levels, and their
distribution in distinct cellular compartments.
Materials and Methods
Reagents
Geldanamycin was purchased from InvivoGen (France). Tissue
culture media, antibiotic cocktail, fetal bovine serum, dimethyl
sulfoxide (DMSO) were purchased from Sigma-Aldrich (Poland).
Horseradish peroxidase-conjugated antibodies against betabeta-
actin, mouse monoclonal anti-Hsp90alpha/beta, mouse monoclo-
nal anti-Hsp70 were purchased with Santa Cruz Biotechnology
(Germany). Mouse monoclonal anti-Hsp60 antibodies were
obtained from Sigma Aldrich (Italy). Rabbit polyclonal antibodies
against Hsp90 alpha and rabbit monoclonal antibodies against
Hsp90 beta were purchased from Abcam (UK). Rabbit polyclonal
antibodies against acetylated lysine was obtained from Cell
Signaling Technology (Italy). Goat anti-mouse and anti-rabbit
IgG antibodies were purchased from Perkin Elmer (USA) and
Abcam (UK), respectively.
Cell line and culture conditions
The human OS 143B cell line was obtained from the American
Tissue Type Collection (ATTC-8303). The cells were cultured at
37uC in a humidified atmosphere saturated with 5% CO2 using
Dulbecco’s Modified Eagle’s medium supplemented with 10%
heat-inactivated fetal bovine serum and a penicillin (100 mg/mL)/
streptomycin (100 mg/mL) cocktail (Sigma-Aldrich, Poland).
Cell treatment
Before each experiment, the cells were trypsinized with a
solution of 0.25% trypsin and 0.02% EDTA, and were cultured
for 24 h under the above-described conditions. The medium was
then replaced with the one containing GA according to an
experimental design. The stock solution of GA was prepared by
dissolving the pure compound in DMSO. The final concentration
of DMSO in the working solution was ,0.001%. After an
appropriate incubation time, the cells were harvested and analyzed
by one of the methods described below.
Cell viability assay (MTT assay)
OS 143B cells were seeded onto 96-well plates at a density of ten
thousand cells/well and cultured for 24 h. Medium was then
removed and cells were treated with serial GA dilutions (within the
range of 0.8 mM–50 mM) of GA for 24 h. After the appropriate
incubation time, 0.5 mg/mL of 3-[4,5-dimethylthiazol-2-yl]-2,5
diphenyltetrazolium bromide (MTT) was added. The plates were
then incubated at 37uC for 4 h and the supernatant was removed.
Finally, 100 mL of DMSO was added. Absorbance at 570 nm was
determined using a microplate reader (Bio-Tek Instruments, Inc.,
USA). The number of cells was calculated based on absorbance
values. The results were presented as a percentage of control. Each
experiment was performed at least three times.
Assessment of apoptosis by flow cytometry with double
Annexin V - propidium iodide (PI) staining
OS 143B cells were seeded onto six-well plates at a density of
three hundred thousand cells/well. After 24 h of culturing in the
standard medium, the cells were treated with GA for 24 h. The
cells were then pelleted and incubated with Annexin V and PI
according to manufacturer’s protocol (BD Pharmingen, Poland).
Afterward, the cells (thirty thousand/sample) were analyzed, and
the fluorescent signals of Annexin V conjugate and PI were
detected at the fluorescence intensity channels FL1 and FL3 (BD
FACScan). The results were then analyzed by Cyflogic software,
version 1.2.1. Each experiment was performed at least three times.
RNA extraction and Real Time PCR analysis
Reverse transcription (1 mg RNA/reaction) was performed with
First Strand cDNA Synthesis Kit (Fermentas). RT PCR was
performed using 5-fold diluted cDNA and RT PCR Master Mix
(A&A Biotechnology). Reactions were performed with the initial
denaturation at 95uC for 5 min (phase I) and then 40 cycles at
95uC for 15 sec, 57uC for 60 sec and 72uC for 20 sec, ending with
fluorescence reading at 78uC for 10 sec (phase II). Melt Curve
stage started with 95uC for 15 sec, next cooling to 70uC
(redenaturation of present products) for 60 sec with temperature
increasing to 95uC, fluorescence read each 0.3uC. The primers
were designed based on the human OS DNA sequence with using
Integrated Device Technology software. Real Time PCR reactions
were performed employing Applied Biosystems StepOnePlus
Real-Time PCR thermocycler and analyzed using StepOne
Software. All qPCR reactions were repeated at least 3 times to
ensure the replicability of the results.
The primers used were as follows:
Hsp90AA1 (F: AGGTTGAGACGTTCGCCTTTCA,
R: AGATATCTGCACCAGCCTGCAA),
Hsp90AB1 (F: AGGAACGTACCCTGACTTTGGT,
R: ATGCCAATGCCTGTGTCTACCA),
Hsp90B1 (F: TGGAGGAAGAAGAAGCAGCCAA,
R: AAGTTCCCAGTCCCAGACAGTT),
Hsp70 (F: AAGGACATCAGCCAGAACAAGCGA,
R: ACGTGTAGAAGTCGATGCCCTCAA),
Hsp60 (F: TTGCTACTGGTGGTGCAGTGTTTG,
R: GCATGGCATCGTCTTTGGTCACAA).
Western blotting
Equal amounts of total cell lysates were resolved by 9% SDS–
PAGE and transferred to PVDF membranes (Amersham Biosci-
ences) by means of semidry transfer (Bio-Rad). The membranes
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were then incubated with primary antibodies anti -total Hsp90, -
Hsp70, -Hsp60, -Hsp90 alpha and -Hsp90 beta (1:1000) overnight
at 4uC. After having been washed 3 times per 5 min with TBS-T,
the membranes were probed with horseradish peroxidase-conju-
gated goat anti-mouse or anti-rabbit IgGs (1:50000) for 1 h at
room temperature (RT). Subsequently, the membranes were
washed 3 times with TBS-T. A visualization step was performed
using a luminol-enhanced chemiluminescence (Chemilumines-
cence Blotting Substrate Kit, GE Healhcare, UK) according to the
manufacturer’s protocol. The protein level was quantified by
densitometry technique using Quantity one 4.5.2 software. The
protein levels, as determined by chemiluminescent quantification,
were normalized relative to beta-actin levels found in the samples.
Each experiment was performed at least three times.
Immunoprecipitation
In order to detect protein complexes immunoprecipitation was
performed as described by Campanella et al. [25]. Briefly, 5 mg of
primary antibody (mouse monoclonal anti-HSP60, Clone LK1,
Sigma-Aldrich) per 1 ml of total cell lysate, were incubated
overnight at 4uC with gentle rotation. Antibody/protein complex-
es were then immunoprecipitated with antibodies linked to
Sepharose A beads (Amersham Biosciences, Italy). Nonspecifically
bound proteins were removed by repeated washing with isotonic
lysis buffer. Immunoprecipitated proteins were resolved by 10%
SDS-PAGE using acetylated lysine primary antibodies (Cell
Signaling, Italy). Each experiment was performed at least three
times.
Immunofluorescent microscopy
143B cells were seeded onto an 8-well microscope chamber slide
at the density of ten thousand cells/well, cultured for 24 h and
then treated with GA. Cells were fixed with ice cold methanol for
30 min, washed in phosphate buffer solution (PBS); pH 7.4, and
were incubated with the unmasking solution (trisodium citrate
10 mM, 0.05% Tween 20) for 10 min at RT. Then, the cells were
incubated with the blocking solution (3% albumin bovine serum in
PBS) for 30 min at RT and with primary antibodies (mouse
monoclonal anti-HSP60, Clone LK1, Sigma-Aldrich; mouse
monoclonal anti-HSP70, W27, Santa Cruz Biotechnology; mouse
monoclonal anti-HSP90 alpha/beta, Santa Cruz Biotechnology,
USA) diluted 1:100, overnight at 4uC. The next day, the cells were
incubated with the other primary antibody (rabbit polyclonal anti-
AIF, H300, Santa Cruz Biotechnology) diluted 1:100 overnight at
4uC for double immunofluorescence analysis.
After washing twice in PBS, the cells were incubated with
fluorescent secondary antibodies such as mouse IgG antibody
conjugated with FITC (Sigma-Aldrich, Italy), mouse IgG antibody
conjugated with Texas Red (Sigma-Aldrich, Italy) both diluted
1:200 for 1 h at RT. Moreover, rabbit IgG antibody conjugated
with Texas Red (diluted 1:200; Gene Tex Inc, Irvine, USA) was
used for the detection of the immunofluorescent complexes. The
nuclei were counterstained with Hoechst 33342 (Sigma-Aldrich,
Inc, Italy) for 15 min at RT. Finally, all slides were mounted with
cover slips using a drop of PBS, and then reading and imaging
were immediately performed using a Leica DM5000 upright
fluorescence microscope (Leica Microsystems, Heidelberg,
Germany).
Statistical analysis
Data from at least three independent experiments are presented
as mean 6 SE. Data were analyzed using GraphPad Prism
(GraphPad Software, Inc., version 6.02, USA). Significant
differences between groups were determined by One-way
ANOVA combined with Dunett’s Multiple Comparison test or
Student’s t-test. *P,0.01 was considered statistically significant.
Results
Effect of GA on proliferation of OS 143B cells
One of the main goals of the study was to determine the
inhibitory effect of GA on highly metastatic human OS 143B cell
line. The cells were treated for 24 h with serial GA dilutions
(within the range of 0.8 mM–50 mM), Subsequently, the inhibition
of 143B cell growth was assessed by means of MTT-assay. GA
effectively inhibited OS cell growth in a concentration-dependent
manner. Viability of 143B cells was significantly decreased from
77% to 23% in the presence of growing concentrations of GA as
compared to control (Figure 1A).
GA induced apoptosis and necrosis in OS 143B cells
In order to determine the influence of 24 h treatment of 143B
OS cells with GA on the induction of cell death, flow cytometric-
double staining (Annexin V and PI) was performed. An increase in
apoptotic and necrotic cells was observed after GA (4 mM)
treatment (Figure 1B–D). The percentage of apoptotic 143B cells
found after 24 h long treatment with GA (4 mM) was equal to
41.5%66% (Figure 1C), while percent of necrotic cells was equal
to 20.9%64.5% (Figure 1D). Precisely, 23.9%62.5% and
17.6%63.5% were found in the early stage and, in the late stage
of apoptosis, respectively (Figure 1B). Moreover, the treatment of
143B cells with 4 mM GA for 6 h resulted in the upregulation of
apoptosis-inducing factor (AIF) as shown by immunofluorescence
(see Impact of GA on Hsp60 level and gene expression).
Impact of GA on Hsp90 gene expression and protein
level
GA is known to bind specifically to the ATP-binding site of
Hsp90AA1 and Hsp90AB1 with similar affinities which results in
the inhibition of Hsp90s interaction with the target proteins [18].
In order to investigate whether GA affects Hsp90 gene expression,
143B cells were treated with GA (4 mM) for 6 h. Subsequently,
Hsp90AA1, Hsp90AB1, and Hsp90B1 mRNA levels were
analyzed by means of Real Time PCR. Interestingly, GA caused
3- and 5-fold increase in the level of HspAB1 and Hsp90AA1
transcript, respectively (Figure 2C–D). However, GA did not
significantly affect ER Hsp90B1 isoform (Figure 2E). The levels of
the studied Hsp90 proteins, as observed in 143B cells after
treatment with GA (4 mM) for 6 h, were also determined by
Western blotting. The obtained data were in accord with those
from Real Time PCR. The treatment of 143B cells with GA
(4 mM) for 6 h resulted in a 1.2-, 5.5-, and 1.3-fold increase in the
protein levels of the total cellular Hsp90, Hsp90AA1, and
Hsp90AB1, respectively, as compared to control (Figure 3C–E).
The effect of GA (4 mM) on the total cellular Hsp90 expression
was then confirmed by immunofluorescence. Five random fields
were acquired for each experimental condition (the representative
picture is presented in Figure 4C). Cell nuclei were stained by
Hoechst 33342 and shown in blue, Hsp90 immunoreactivity was
shown in red. Treatment of 143B cells with GA (4 mM)
remarkably increased the total cellular Hsp90 as compared to
control (see Impact of GA on Hsp60 level and gene
expression).
Impact of GA on Hsp70 level and gene expression
GA can activate HSF1 which results in the induction of Hsp70
as previously demonstrated in certain experimental models, e.g.
K562 erythroleukemic or rat 9L gliosarcoma cells [19], [21]. GA-
Impact of Geldanamycin on HSPs in Osteosarcoma
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induced upregulation of Hsp70 has been recently linked to
chemotherapy resistance [15], [26]–[][28]. In this study, we
demonstrated that OS treatment with GA (4 mM) for 6 h resulted
in a 233-fold increase in the Hsp70 transcript level as compared to
control (Figure 2B). These results were in accord with the elevated
Hsp70 protein levels as shown by Western blotting (Figure 3B). A
5-fold increase in the protein level of Hsp70 was observed in
response to 6 h treatment with GA (4 mM) (Figure 3B). The
upregulation of Hsp70 protein level by GA (4 mM) in 143B cell
line was also visualized using immunofluorescence technique. Five
random fields were acquired for each experimental condition (the
representative picture is presented in Figure 4B). Cell nuclei were
stained by Hoechst 33342 and shown in blue, Hsp70 immuno-
reactivity was shown in green. The obtained results showed a
significant increase in the Hsp70 protein level as observed in GA-
treated cells (Figure 4B).
Impact of GA on Hsp60 level and gene expression
Not much is known about the effects of GA on the
mitochondrial chaperone Hsp60, involved in the regulation of
OS cell proliferation [9]. Thus, our goal was to determine the
impact of GA on Hsp60 gene expression. Treatment with GA
(4 mM) resulted in a 2.4-fold induction of Hsp60 gene expression
in 143B cells after 6 h incubation (Figure 2A). On the other hand,
the data obtained from immunofluorescense analysis indicated
decreased Hsp60 protein level observed after 6 h treatment of
143B cells with GA as compared to control (Figure 3A). The effect
of GA was then confirmed by Western blotting. Interestingly, a
20% decrease in the level of Hsp60 in GA-treated 143B cells
(Figure 3A). Moreover, after 6 h treatment with GA, an extra
band corresponding with slightly higher molecular weight was
identified by standard Western blotting. The occurrence of some
additional immunoreactivity suggested a possible post-translational
Figure 1. The effect of GA on proliferation and induction of cell death of OS 143B cells. A. GA inhibits OS 143B cell growth. OS 143B cells
were treated for 24 h with serial GA dilutions (within the range of 0.8 mM–50 mM). The cell viability was then determined by means of MTT assay. Data
from at least three independent experiments are presented as mean 6 SE. The absence of error bar denotes a line thickness greater than the error.
Data were analyzed by GraphPad Prism Software version 6.02 performing One-way ANOVA combined with Dunett’s Multiple Comparison Test.
*P,0.01 vs. control. B–D. GA induced cell death of OS 143B cells. 143B OS cells were treated with 4 mM GA for 24 h, the cells were then harvested
and the percentage of apoptotic and necrotic cells was determined performing double PI-Annexin V staining. B. Annexin V, PI-live/dead dot plots
showing apoptosis and necrosis before and after treatment with GA. Plots are representative of five individual experiments. C–D. Total apoptotic (C)
and necrotic (D) cell number before and after treatment with GA. Data from at least three independent experiments are presented as mean 6 SE.
Data were analyzed using GraphPad Prism (GraphPad Software, Inc., version 6.02, USA). Significant differences between groups were determined by
Student’s t-test. *P,0.01, ***P,0.0001 vs. control.
doi:10.1371/journal.pone.0071135.g001
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Figure 2. GA affected HSPs gene expression in OS 143B cells. OS 143B cells were treated with GA (4 mM) for 6 h; the levels of Hsp60, Hsp70,
Hsp90AA1, Hsp90AB1, Hsp90B1 transcript were then determined by means of Real Time PCR. Treatment with GA resulted in upregulation of Hsp60
(A), Hsp70 (B), Hsp90AA1 (C), Hsp90AB1 (D) transcript, however it did not impact Hsp90B1 gene expression (E). Values are mean 6 SE of three
independent experiments, relative mRNA levels of HSP/beta-actin are presented. The data were analyzed by Student’s t-test using GraphPad Prism
Software version 6.02. *P,0.01, **P,0.001 vs. control.
doi:10.1371/journal.pone.0071135.g002
Figure 3. GA affected HSPs protein levels in OS 143B cells. OS 143B cells were treated with 4 mM GA for 6 h; the levels of Hsp60, Hsp70, total
cellular Hsp90, Hsp90AA1, Hsp90AB1proteins were determined by Western blotting. A. GA decreased the level of Hsp60 and induced post-
translational modification of Hsp60 partially derived from the hyperacetylated isoform. B–E. GA upregulated Hsp70 (B), total cellular Hsp90 (C),
Hsp90AA1 (D), Hsp90AB1 (E) protein levels. Each experiment was performed at least three times. The representative data are shown. Densitometric
analysis of HSP/beta-actin was performed using Quantity one 4.5.2 software.
doi:10.1371/journal.pone.0071135.g003
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modification of Hsp60 after treatment with GA (Figure 3A).
Interestingly, Singh et al. [29] demonstrated that cytosolic and
mitochondrial forms of Hsp60 differed in their molecular weight.
That is why, the exact localization of Hsp60 within the cellular
compartments of OS 143B was investigated before and after GA
treatment. Mitochondrial localization of Hsp60 was confirmed
using double-labeled immunofluorescent microscopy. AIF played
a role of natural marker of mitochondria. Five random fields were
acquired for each experimental condition (the representative
picture is presented in Figure 4A). Cell nuclei were stained by
Hoechst 33342 and shown in blue, Hsp60 immunoreactivity was
shown in green, AIF immunoreactivity in red. The merge of
Hsp60, AIF and cell nuclei (orange) was also presented. It was
demonstrated that GA (4 mM) did not influence Hsp60 localiza-
tion, which suggests that the extra band visualized by Western
blotting is not the cytosolic Hsp60 (Figure 4A). One of the essential
post-translational modification affecting HSPs function is their
hyperacetylation [31]. In order to determine if hyperacetylation
was induced by GA, a double-labeled immunoprecipitation of
acetylated lysine and Hsp60 was performed. Interestingly, the
obtained results confirmed that the additional band of Hsp60 as
visualized on Western blot might at least to some extent derive
from GA-induced post-translational hyperacetylation of Hsp60
protein.
Discussion
Previous reports have clearly established that Hsp90 and other
chaperones are required for survival of both normal and malignant
cells, and have served as useful cancer biomarkers [5], [31]. OS is
one of many cancers with poor prognosis, and the resistance of OS
to chemotherapy is partly associated with overexpression of HSPs
[11]. The upregulation of HSPs is believed to be tied in to tumor
progression, sustained cancer cell proliferation, development of
drug resistance and long-term cellular adaptation [32], [33]. In
our study, we followed the effects of GA on the major HSPs
(Hsp90, Hsp70, Hsp60) localized in distinct cellular compartments
(cytosol, mitochondria, ER) of highly metastatic OS 143B cells.
Figure 4. Effect of GA on localization and protein level of HSPs in OS 143B cells. OS 143B cells were treated with 4 mM GA for 6 h; the levels
of Hsp60, Hsp70, total cellular Hsp90 protein were determined by immunofluorescence. A. GA did not change the mitochondrial localization of
Hsp60, however, it decreased the mitochondrial pool of the protein. Cell nuclei were shown in blue while Hsp60, AIF immunoreactivities in green and
red, respectively. Merged image of all kinds of staining (orange) was also presented. B. GA upregulated Hsp70 protein level. Cell nuclei were shown in
blue, while Hsp70 immunoreactivity in green. Merged image of both was also presented. C. GA upregulated Hsp90 protein level. Cell nuclei were
shown in blue while Hsp90 immunoreactivity in red. Merged image of both was also presented. Original magnification640. Each experiment was
performed at least three times. The representative data were shown.
doi:10.1371/journal.pone.0071135.g004
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Our findings demonstrated that GA is a potent inhibitor of 143B
cell growth and programmed cell death inducer (Figure 1A–D)
suggesting that it could be potentially effective in OS chemother-
apy. It has been known that GA inhibits the activity of Hsp90.
However, the molecular mechanism leading to GA-induced cell
death still remains to be elucidated. Kim et al. [19] presented that
GA activated HSF1 transcription factor, which resulted in the
upregulation of HSPs gene expression. The modulation of HSPs
expression was later confirmed by Sittler et al. [34] showing the
upregulation of Hsp70 and Hsp90 in COS-1 cells treated with GA.
Here, we presented that the anticancer activity of GA seemed to
be associated with GA impact on the mitochondrial and cytosolic
expression of the major HSPs. According to our data GA
upregulated cytosolic isoforms of Hsp90 (Hsp90AA1, Hsp90AB1)
whereas it had no effect on ER Hsp90B1 level in GA-treated 143B
cells (Figure 2C–E). GA treatment resulted in a comparable
induction of Hsp90AA1 gene expression and protein synthesis in
143B cells (Figure 3D), whereas GA-stimulated transcription of
Hsp90AB1 gene did not correlate with Hsp90AB1 protein level as
observed in 143B cells (Figure 3E). This finding might suggest
different control mechanisms of Hsp90AB1 protein synthesis that
do not correlate with mRNA levels. It is not surprising in light of
higher inducible potential of Hsp90AA1 as observed in the rat 9L
gliosarcoma cells [13]. Nevertheless, the impact of GA on 143B
cells seems to be dependent on the cell line and GA concentration.
Chang et al. showed diminished expression of Hsp90AA1 in
comparison with Hsp90AB1 after 5 h treatment with 0.5 mM GA
which contradicts de novo synthesis of the studied proteins as
observed in rat gliosarcoma 9L cells [13]. In the urinary bladder
cancer cells, Karkoulis et al. showed the downregulation of the total
cellular Hsp90 caused by 17-AAG at concentrations below
0.1 mM, while the upregulation was observed at concentrations
above 1 mM [35]. Furthermore, we presented that GA treatment
highly induced Hsp70 gene expression. (Figure 2, 3, 4B).
Regarding recent findings in terms of pharmacological induction
of Hsp70 and Hsp90 as one of the principal factors leading to
cancer development, metastasis and drug resistance [36], [8], as
well as the HSPs upregulation observed in our studies, we decided
that it might be of importance to determine the impact of GA on
yet another essential HSPs protein, namely Hsp60. It was proven
that the Hsp60 knockdown contributed to OS cell arrest [9], [37].
For the first time we demonstrated that GA treatment of OS 143B
cells resulted in cell death (Figures 1A–C), which seems to coincide
with hyperacetylation and decreased level of mitochondrial Hsp60
(Figure 3–4A). Hsp60 (as well as many other chaperones) is known
to form numerous complexes, and the deregulation of Hsp60
activity, possibly via acetylation, can disturb protein folding in
the cell [37], and cause proteotoxic stress ultimately resulting in
the switch of prosurvival signaling to cancer cell autoelimination
[38]. Our previous data strongly suggest that acetylation of
interphase microtubules in OS 143B cells can be an essential
molecular mechanism of mitochondrial biogenesis regulation
[38]. Interestingly, reversible hyperacetylation was shown to
deregulate the Hsp90 and Hsp70 chaperone functions, and to
affect a great number of mitochondrial metabolic pathways [5],
[30]. There are no data concerning the regulation of Hsp60
activity via acetylation, however, Sol et al. demonstrated that
Hsp60 was one of the proteins undergoing acetylation in U2OS
OS cells with sirtuine 3 (Sirt3) knockout [39]. Sirtuins play an
essential role in the regulation of mitochondrial oxidative stress
and tumorigenesis [39]–[][41]. In 2007, Lombard et al.
suggested that Sirt3 knockdown led to substantial hyperacetyla-
tion of the mitochondrial protein [41]. On the other hand,
protein deacetylation has been found to enhance xenobiotic
liver injury by modulating the binding of toxic metabolite of
acetaminophen to the mitochondrial protein [42]. Such a
strategy can be applied in the treatment of tumors using
hepatotoxins like acetaminophen as anticancer enhancers [43].
That is one of the major reasons why sirtuins and other
deacetylases have been recently investigated in order to
elucidate their potential role in GA-induced hyperacetylation
of Hsp60.
The process of hyperacetylation of Hsp60 as well as other
chaperones (Hsp70 and Hsp90) seems to be an emerging target for
chemotherapeutic treatment of patients presenting with OS. GA
and GA less toxic derivatives might be good candidates for
combined adjuvant and/or neoadjuvant chemotherapy.
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